ArticleEuropean journal of haematology2021

CDK 4/6 inhibitors are associated with a high incidence of thrombotic events in women with breast cancer in real-world practice.

Malinda T West et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.